Press release
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share, Size, Trends, Analysis, Outlook, Research Report and Forecast Period of 2024-2032
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
According to a new report by Expert Market Research titled, "Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Share, Analysis, Report and Forecast 2024-2032″, the global phosphoinositide 3-kinase (PI3K) inhibitors market size is projected to grow at a CAGR of 4.65% between 2024 and 2032. Aided by the development in the field of targeted therapy and the rising prevalence of cancer globally, the market is expected to grow significantly by 2032.
Get a Free Sample Report with Table of Contents@ https://www.expertmarketresearch.com/reports/phosphoinositide-3-kinase-inhibitors-market/requestsample
Phosphoinositide 3-kinase inhibitors, commonly abbreviated as PI3K inhibitors, are considered as a revolutionary class of drugs specifically targeted for oncology therapeutics. They function by impeding the action of PI3K in cancer cells, thus hindering their proliferation and survival. Scientifically, PI3K has been recognised to play an instrumental role in the modulation of cellular functions related to growth, survival, and metabolism. Given its central role in tumour progression and survival, the emergence of PI3K inhibitors offers a promising pathway for targeted cancer therapeutics.
One of the primary factors boosting the phosphoinositide 3-kinase (PI3K) inhibitors market growth is the robust pipeline of PI3K inhibitors and their evident efficacy in clinical trials. The drugs have demonstrated profound potential, particularly against blood cancers like chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL). Several pharmaceutical companies are allocating hefty investments towards research and development activities.
Furthermore, the phosphoinositide 3-kinase (PI3K) inhibitors market demand is supported by the increasing demand for personalised medicines and targeted therapies in the oncological realm. Unlike conventional chemotherapy, which indiscriminately affects all rapidly dividing cells, targeted therapies like PI3K inhibitors selectively target cancer cells, minimising collateral damage to healthy cells. This specificity not only augments therapeutic outcomes but also curtails the side-effects typically associated with cancer treatments.
The phosphoinositide 3-kinase (PI3K) inhibitors market size is likely to benefit from the advances in therapeutic landscape of haematological malignancies as a result of rising government support. PI3K inhibitors are capable of treating a variety of blood cancers. As the medical community becomes more cognizant of the drug's efficacy, its integration into standard therapeutic protocols is likely to increase.
In addition to their direct antitumour activity, PI3K inhibitors are progressively being acknowledged for their synergistic potential. The ability of these drugs to enhance the efficacy of other concurrent treatments, especially in combination therapeutic procedures, is likely to propel the phosphoinositide 3-kinase (PI3K) inhibitors market growth further. Moreover, the potential of PI3K inhibitors to boost the effectiveness of other anticancer agents also enhances the clinical outcomes.
Read Full Report with Table of Contents@ https://www.expertmarketresearch.com/reports/phosphoinositide-3-kinase-inhibitors-market
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segmentation
The market can be divided based on application and region.
Market Breakup by Application
CLL - Chronic Lymphocytic Leukaemia
FL - Follicular Lymphoma
Market Breakup by Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global phosphoinositide 3-kinase (PI3K) inhibitors market. Some of the major players explored in the report by Expert Market Research are as follows:
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Verastem Inc.
Others
Read More:
Top Honey Companies: https://www.expertmarketresearch.com/articles/top-honey-companies
Load Bank Market: https://www.expertmarketresearch.com/reports/load-bank-market
Liver Cancer Screening Market: https://www.expertmarketresearch.com/reports/liver-cancer-screening-market
Immunodiagnostics Market: https://www.expertmarketresearch.com/reports/immunodiagnostics-market
Immune Thrombocytopenia Market: https://www.expertmarketresearch.com/reports/immune-thrombocytopenia-market
Hyperbaric Oxygen Therapy (HBOT) Market: https://www.expertmarketresearch.com/reports/hyperbaric-oxygen-therapy-hbot-market
Top 6 Companies Revolutionising the Air Purifier Market: https://www.expertmarketresearch.com/articles/top-air-purifier-companies
Top 6 Companies in the Global Silicon Photonics Market: https://www.expertmarketresearch.com/articles/top-6-companies-global-silicon-photonics-market
Top 4 Companies in the Chlorine Market: https://www.expertmarketresearch.com/articles/top-4-companies-global-chlorine-market
Media Contact
Company Name: Claight Corporation
Contact Person: Louis Wane, Corporate Sales Specialist - U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share, Size, Trends, Analysis, Outlook, Research Report and Forecast Period of 2024-2032 here
News-ID: 3308642 • Views: …
More Releases from Expert Market Research
AI in Mental Health Market to Reach USD 8.38B by 2035
How Is Artificial Intelligence Transforming Mental Healthcare?
The Artificial Intelligence in Mental Health Market is rapidly emerging as a transformative force in global healthcare, addressing long-standing challenges such as access, affordability, stigma, and workforce shortages. With more than 970 million people worldwide affected by mental health conditions, the need for scalable, personalized, and data-driven mental health solutions has never been more urgent.
The global artificial intelligence in mental health market was valued…
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Why is the Brazil Clinical Microbiology Market gaining strategic importance within Latin America's healthcare ecosystem?
Brazil has one of the largest and most complex healthcare systems in the region, with a growing focus on early disease detection, antimicrobial resistance monitoring, and laboratory automation. Clinical microbiology plays a critical role in identifying infectious diseases, guiding targeted therapies, and supporting public health surveillance.
The Brazil clinical microbiology market was valued at USD 390.12 Million…
Battery Recycling Market Size, Trends and Forecast 2026-2035
The battery recycling market is gaining steady traction as industries and governments focus more on resource efficiency, environmental compliance, and supply chain security for critical metals. With the rising use of lithium-ion, lead-acid, and nickel-based batteries across electric vehicles, consumer electronics, industrial equipment, and energy storage systems, recycling has moved from being a regulatory requirement to a strategic necessity. Battery recycling helps recover valuable materials like lithium, cobalt, nickel, and…
Biometrics Technology Market Size, Trends & Forecast 2026-2035
The biometrics technology market is witnessing robust growth and is expected to continue expanding at a significant pace. Valued at approximately USD 27.78 billion in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 10.20% between 2026 and 2035. By 2035, the market is expected to reach USD 73.38 billion. This growth is driven by the increasing need for advanced security solutions, innovations in…
More Releases for PI3K
PI3K Inhibitors Market Outlook: Roche, Novartis, and Emerging Biotechs Drive Com …
DelveInsight's comprehensive analysis reveals robust growth potential in the PI3K inhibitors market across 7MM through 2034. Key players include Roche/Genentech (ITOVEBI), Novartis (PIQRAY), Gilead Sciences (ZYDELIG), Kazia Therapeutics (Paxalisib), Celcuity (Gedatolisib), and others, with expanding applications from hematological to solid tumor indications driving market momentum.
PI3K Inhibitor Key Takeaways
*
PI3K Inhibitor market size projection: As per DelveInsight's analysis, the total market size of PI3K inhibitors in the 7MM is expected to…
PI3K Inhibitors Market Projected to Witness Massive Growth - Novartis, Gilead Sc …
PI3K Inhibitors Market Snapshot
The PI3K Inhibitors Market is projected to reach USD 2.5 billion by 2032, growing at a CAGR of 8.2% from 2025 to 2032.
Coherent Market Insights proudly presents its latest PI3K Inhibitors Market Research Report, delivering a detailed examination of the U.S. PI3K Inhibitors Market outlook from 2025 to 2032. This comprehensive analysis provides strategic forecasts at both national and regional levels, addressing evolving supply networks, payer-provider collaboration,…
Global Jak And Pi3k Signaling Pathway Market Size by Application, Type, and Geog …
According to Market Research Intellect, the global Jak And Pi3k Signaling Pathway market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The JAK and PI3K signaling pathway market is experiencing significant growth due to the increasing…
PI3K inhibitors Pipeline Insights, Clinical Trials, Emerging Therapies and Compa …
DelveInsight's, "PI3K inhibitors Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs based on PI3K inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the PI3K…
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Segmentation Analysis and Glo …
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Overview
Metabolism of the human body relies on a variety of factors, and proper metabolism is essential to prevent several diseases. The development of tumours inside the body is largely due to improper cycles of metabolism. Medical researchers have demonstrated commendable accountability in dealing with chronic disorders and diseases. The cellular functions that run inside the body need be controlled and manoeuvred through proper drug…
Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Exclusive insight on Transfor …
Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market: Overview
Metabolism of the human body relies on a variety of factors, and proper metabolism is essential to prevent several diseases. The development of tumours inside the body is largely due to improper cycles of metabolism. Medical researchers have demonstrated commendable accountability in dealing with chronic disorders and diseases. The cellular functions that run inside the body need be controlled and manoeuvred through proper drug…
